Awards as PI
| Funding | ||
|---|---|---|
| Tools and Technologies II | Antibody tools to deplete or isolate teratogenic, cardiac, and blood stem cells from hESCs | $1,869,487 |
| Comprehensive Grant | Prospective isolation of hESC-derived hematopoietic and cardiomyocyte stem cells | $2,636,900 |
| Disease Team Research I | Development of Therapeutic Antibodies Targeting Human Acute Myeloid Leukemia Stem Cells | $19,999,996 |
Total: $24,506,383.00 |
